Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 4, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
Aimovig · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAjovy · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAkeega · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenAkeega · 4.3 · Severe hepatic impairment [Child-Pugh Class C (see sections 4.2, 4.4 and 5.2)].
Eintrag öffnenAkeega · 4.3 · Women who are or may become pregnant (see section 4.6).
Eintrag öffnenAkynzeo · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenAkynzeo · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenAkynzeo · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenAkynzeo · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenAkynzeo · 4.3 · Pregnancy (see section 4.6).
Eintrag öffnenAkynzeo · 4.3 · Pregnancy (see section 4.6).
Eintrag öffnenAkynzeo · 4.3 · Pregnancy (see section 4.6).
Eintrag öffnenAkynzeo · 4.3 · Pregnancy (see section 4.6).
Eintrag öffnenAldara · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAldara · 4.8 · Imiquimod was investigated in controlled clinical studies with paediatric patients (see sections 4.2 and 5.1).
Eintrag öffnenAlecensa · 4.3 · Hypersensitivity to alectinib or to any of the excipients listed in section 6.1.
Eintrag öffnenAlecensa · 4.8 · Patients should be monitored for liver function including ALT, AST, and total bilirubin as outlined in section
Eintrag öffnenAlimta · 4.3 · Breast-feeding (see section 4.6).
Eintrag öffnenAlimta · 4.3 · Concomitant yellow fever vaccine (see section 4.5).
Eintrag öffnenAlimta · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnen